Clinical Trial: Molecular Signatures of Cutaneous Dupilumab Response
Study Status: Completed
Recruit Status: RECRUITING
Condition: Atopic Dermatitis
Study Type: INTERVENTIONAL
Official Title: Molecular Signatures of Cutaneous Dupilumab Response
Brief Summary:
This study examines the effect of IL4RA blockade with dupilumab on the immune cells of atopic dermatitis skin lesions.
Read more